Could hallucinogenic drugs become part of mainstream NHS care to treat depression?
Presentations will feature encore Phase 1 data highlighting the mechanism of action, redosing potential, and early C-peptide ...
On October 6 at 9:00 a.m. CT, tune in to conversations with Greater Houston Partnership president and CEO Steve Kean, Rice University Biotech Launch Pad executive director Paul Wotton and Texas state ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is proud to announce the inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026 ...
Five-month initiative connects more than 1,380 young people with clinical research education, mentorship, scholarships ...
Cronos token burn removes 228 million CRO as voters approve monthly buybacks using all Ult and Cronos Launch revenue. Get ...
Cronos community approved burning 228 million CRO and funding monthly buybacks with Ult and Cronos Launch revenue, passing with 99.78% support on Oct 4.
Cronos Network has executed a token burn of its native coin $CRO. The value of this burn is $15M at the current market price ...
In November, clinical operations professionals will gather to discuss challenges reshaping clinical trials at the OCT DACH meeting.
Cronos (CRO) fell 6.9% as US House Oversight Committee expanded probe to Crypto.com, triggering token-specific selling in a ...
AIG has promoted global chief actuary Turab Hussain to CRO, effective from next Monday. Mr Hussain, based in New York, will take over from Christopher Schaper who has informed the company that he ...
The Philippines is seeking to position itself as Asia’s next clinical research hub, with a new center of excellence targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results